Shareholders' Meeting

The 91st Annual General Meeting of Shareholders (Jun 26, 2013)

Date June 26, 2013 (Wednesday)
Place ANA Crowne Plaza Osaka Hotel
Open 10:00 a.m.
Close 10:55 a.m.
The number of shareholders in attendance 257

Notice of Resolutions

Sekisui Chemical Co., Ltd. hereby informs you of the matters reported and the matters resolved at the 91st Annual General Meeting of Shareholders held on June 26, 2013 as follows.

Matters reported:

Report on the Business Report, the Consolidated Accounting Documents, the Non-Consolidated Accounting Documents and the report on the Results of the Audits of Consolidated Accounting Documents by the Accounting Auditor and the Board of Corporate Auditors for the 91st Business Term (from April 1, 2012 to March 31, 2013).

Matters resolved:
First Item of Business

Appropriation of Surplus
The proposed appropriation of surplus has been approved and it was resolved the year-end dividend be 9 yen per share.

Second Item of Business

Appointment of Eight (8) Directors

As proposed, eight (8) Directors have been elected. The names of the Directors are as follows.

Naofumi Negishi
Takayoshi Matsunaga
Teiji Kouge
Hajime Kubo
Kozo Takami
Satoshi Uenoyama
Toru Nagashima*
Kunio Ishizuka*

*Messrs. Nagashima and Ishizuka are outside Directors.

Third Item of Business

Appointment of One (1) Corporate Auditor

As proposed, one (1) Corporate Auditor has been elected. The name of the Corporate Auditor is as follows.

Hiroshi Osada*

*Messrs.Mr. Osada is an outside Corporate Auditor.

Fourth Item of Business

Issuance of Stock Acquisition Rights under the Stock Option Plan

As proposed, it has been approved that the Company would issue stock acquisition rights to representative directors, a certain portion directors and key employees of subsidiaries and representative director of the four (4) affiliated companies (of which the Company holds more than 35% voting rights) of Sekisui Chemical Group, for the purpose of granting stock options, pursuant to the provisions of Articles 236, 238 and 239 of the Companies Act, and that the Company would delegate the determination of the terms and conditions thereof to the Board of Directors of the Company.